Free Trial

Collegium Pharmaceutical (COLL) SEC Filings & 10K Form

Collegium Pharmaceutical logo
$31.78 -0.33 (-1.03%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$31.76 -0.02 (-0.05%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Collegium Pharmaceutical SEC Filings

DateFilerForm TypeView
07/08/2025
3:19 PM
Collegium Pharmaceutical (Subject)
Heffernan Michael Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:04 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
12:02 PM
Collegium Pharmaceutical (Subject)
Freund John Gordon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
3:32 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:32 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:32 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:33 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:33 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:34 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:34 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:34 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:34 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
06/06/2025
3:35 PM
Collegium Pharmaceutical (Filer)
Form S-8 POS
05/19/2025
4:35 PM
Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2025
4:37 PM
Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:39 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:42 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:43 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:43 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
7:10 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
10:04 AM
Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
Form SCHEDULE 13G/A
05/02/2025
9:33 AM
Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
Form SCHEDULE 13G
04/28/2025
6:56 AM
BlackRock, Inc. (Filed by)
Collegium Pharmaceutical (Subject)
Form SCHEDULE 13G/A
03/24/2025
4:05 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:06 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:35 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2025
3:21 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:32 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:17 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:19 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:34 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:36 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:18 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4/A
03/18/2025
4:34 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
3:49 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
3:50 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
03/07/2025
3:13 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
5:48 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:43 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:05 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
9:42 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
2:03 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2025
12:21 PM
Collegium Pharmaceutical (Subject)
Invesco Ltd. (Filed by)
Form SCHEDULE 13G
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:12 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM
Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:13 PM
Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
Form SC 13G
11/13/2024
3:30 PM
Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/13/2024
1:39 PM
Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SCHEDULE 13G
09/17/2024
3:32 PM
Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
9:39 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
9:06 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
4:52 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
10:53 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:47 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
1:41 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:34 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:02 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COLL) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners